Biomerica (NASDAQ: BMRA) had its outperform rating reissued by analysts at Zacks. The firm currently has a $2.70 target price on the stock. Zacks’ analyst wrote, “Biomerica has been profitable over nine of the last ten quarters, has regularly generated positive cash flow, and maintains a stellar balance sheet. We think it is clear that management and the board lead the company in a way with an eye on increasing shareholder value. We have come across few companies that have been in existence over 40 years, possess all of the positive characteristics of BMRA and yet trade at what we would characterize as an incredibly cheap valuation. We see very little to no downside risk in the share price at this level. We think the cheap valuation may have more to do with BMRA being a nano-cap and suffering from a lack of exposure rather than having anything to do with fundamentals. “
Informed investors can connect the dots before the un-informed strap hangers even can start to onderstand what is going on. Do your due diligence and be prepared...........oldmanbadman rdncoic
Why else would an investor jump in now with a 5% buy at a premium, $1.25 a share, if the big boys didn't know what was going on? :):) :)
Recent BMRA News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/20/2024 09:00:04 PM
- The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer • GlobeNewswire Inc. • 09/04/2024 12:19:00 PM
- Biomerica Reports Fiscal 2024 Year End Results • GlobeNewswire Inc. • 08/29/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/28/2024 09:00:33 PM
- Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers • GlobeNewswire Inc. • 07/01/2024 11:47:00 AM
- Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 • GlobeNewswire Inc. • 05/13/2024 12:19:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/10/2024 09:20:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 09:15:25 PM
- Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement • GlobeNewswire Inc. • 04/29/2024 12:19:00 PM
- Biomerica provides update on inFoods® IBS expansion • GlobeNewswire Inc. • 04/15/2024 11:47:00 AM
- Biomerica Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/12/2024 11:23:53 PM
- Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference • GlobeNewswire Inc. • 03/28/2024 12:19:00 PM
- Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board • GlobeNewswire Inc. • 02/21/2024 01:19:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:00:06 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/09/2024 08:06:57 PM
- Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica • GlobeNewswire Inc. • 01/23/2024 01:19:00 PM
- Biomerica Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 01/16/2024 01:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 12:00:32 PM
- Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population • GlobeNewswire Inc. • 12/18/2023 12:47:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 10:10:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 10:10:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 10:10:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 10:10:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 10:10:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 10:10:25 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM